Rapid detection of hepatitis B virus surface antigen by an agglutination assay mediated by a bispecific diabody against both human erythrocytes and hepatitis B virus surface antigen

Clinical and Vaccine Immunology

Volumn 14, Issue 6, 2007, Pages 720-725

  Chen, Yu Ping ^a,b   Qiao, Yuan Yuan ^b   Zhao, Xiao Hang ^b   Chen, Hong Song ^c   Wang, Yan ^b,d   Wang, Zhuozhi ^d  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NAVY GENERAL HOSPITAL   (China)

^c PEKING UNIVERSITY   (China)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BISPECIFIC ANTIBODY; ERYTHROCYTE ANTIBODY; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

AGGLUTINATION TEST; ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN DETECTION; ARTICLE; BLOOD SMEAR; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HEAVY CHAIN; HEMAGGLUTINATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOASSAY; INTERMETHOD COMPARISON; LIGHT CHAIN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, BISPECIFIC; ERYTHROCYTE AGGREGATION; ERYTHROCYTES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOASSAY; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 34547112254     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00310-06     Document Type: Article

References (30)

1. Adams, G. P., J. E. McCartney, M. S. Tai, H. Oppermann, J. S. Huston, W. F. Stafford III, M. A. Bookman, I. Fand, L. L. Houston, and L. M. Weiner. 1993. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv. Cancer Res. 53:4026-4034.
2. Barbas, C. F., III, A. S. Kang, R. A. Lerner, and S. J. Benkovic. 1991. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc. Natl. Acad. Sci. USA 88:7978-7982.
3. Bruenke, J., K. Barbin, S. Kunert, P. Lang, M. Pfeiffer, K. Stieglmaier, D. Niethammer, B. Stockmeyer, M. Peipp, R. Repp, T. Valerius, and G. H. Fey. 2005. Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16). Br. J. Haematol. 130:218-228.
4. Cumber, A. J., E. S. Ward, G. Winter, G. D. Parnell, and E. J. Wawrzynczak. 1992. Comparative stabilities in vitro and in vivo of a recombinant mouse antibody FvCys fragment and a bisFvCys conjugate. J. Immunol. 149:120-126.
5. de Kruif, J., and T. Logtenberg. 1996. Leucine zipper dimerized bivalent and bispecific scFv antibodies from a semi-synthetic antibody phage display library. J. Biol. Chem. 271:7630-7634.
6. FitzGerald, K., P. Holliger, and G. Winter. 1997. Improved tumour targeting by disulfide stabilized diabodies expressed in Pichia pastoris. Protein Eng. 10:1221-1225.
7. Govender, M., M. O. Bubb, and J. D. Conradie. 1985. Rapid purification of HBsAg from human plasma. J. Virol. Methods 11:225-230.
8. Gruber, M., B. A. Schodin, E. R. Wilson, and D. M. Kranz. 1994. Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli. J. Immunol. 152:5368-5374.
9. Holliger, P., T. Prospero, and G. Winter. 1993. "Diabodies": small bivalent and bispecific antibody fragments. Proc. Natl. Acad. Sci. USA 90:6444-6448.
10. Kipriyanov, S. M., S. Dubel, F. Breitling, R. E. Kontermann, and M. Little. 1994. Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies. Mol. Immunol. 31:1047-1058.
11. Kostelny, S. A., M. S. Cole, and J. Y. Tso. 1992. Formation of a bispecific antibody by the use of leucine zippers. J. Immunol. 148:1547-1553.
12. Luo, K. 2001. Hepatitis B: basic biology and clinical science, 2nd ed. People's Medical Publishing House of China, Beijing, China.
13. Mack, M., G. Riethmuller, and P. Kufer. 1995. A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity. Proc. Natl. Acad. Sci. USA 92:7021-7025.
14. McCafferty, J., A. D. Griffiths, G. Winter, and D. J. Chiswell. 1990. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348:552-554.
15. McCartney, J. E., M. S. Tai, R. M. Hudziak, G. P. Adams, L. M. Weiner, D. Jin, W. F. Stafford III, S. Liu, M. A. Bookman, A. A. Laminet, et al. 1995. Engineering disulfide-linked single-chain Fv dimers [(sFv′)2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv′)2 and anti-c-erbB-2 741F8 (sFv′)2 made by protein folding and bonded through C-terminal cysteinyl peptides. Protein Eng. 8:301-314.
16. McGregor, D. P., P. E. Molloy, C. Cunningham, and W. J. Harris. 1994. Spontaneous assembly of bivalent single chain antibody fragments in Escherichia coli. Mol. Immunol. 31:219-226.
17. Milstein, C., and A. C. Cuello. 1983. Hybrid hybridomas and their use in immunohistochemistry. Nature 305:537-540.
18. Munro, S., and H. R. Pelham. 1984. Use of peptide tagging to detect proteins expressed from cloned genes: deletion mapping functional domains of Drosophila hsp70. EMBO J. 3:3087-3093.
19. Neri, D., C. de Lalla, H. Petrul, P. Neri, and G. Winter. 1995. Calmodulin as a versatile tag for antibody fragments. Bio/Technology 13:373-377.
20. Offner, S., R. Hofmeister, A. Romaniuk, P. Kufer, and P. A. Baeuerle. 2006. Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells. Mol. Immunol. 43: 763-771.
21. Orlandi, R., D. H. Gussow, P. T. Jones, and G. Winter. 1989. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86:3833-3837.
22. Pack, P., M. Kujau, V. Schroeckh, U. Knupfer, R. Wenderoth, D. Riesenberg, and A. Pluckthun. 1993. Improved bivalent miniantibodies, with identical avidity as whole antibodies, produced by high cell density fermentation of Escherichia coli. Bio/Technology 11:1271-1277.
23. Pack, P., and A. Pluckthun. 1992. Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli. Biochemistry 31:1579-1584.
24. Perez, L., M. Ayala, G. Pimentel, H. Bell, L. Canaan-Haden, M. Bequet, L. J. Gonzalez, M. Miranda, R. Ravelo, L. Roque, B. Acevedo, J. P. Oliva, and J. V. Gavilondo. 2006. A multivalent recombinant antibody fragment specific for carcinoembryonic antigen. Biotechnol. Appl. Biochem. 43:39-48.
25. Reusch, U., M. Sundaram, P. A. Davol, S. D. Olson, J. B. Davis, K. Demel, J. Nissim, R. Rathore, P. Y. Liu, and L. G. Lum. 2006. Anti-CD3 X anti-epidermal growth factor receptor (EGFR) bispecific antibody redirects T-cell cytolytic activity to EGFR-positive cancers in vitro and in an animal model. Clin. Cancer Res. 12:183-190.
26. Schlereth, B., C. Quadt, T. Dreier, P. Kufer, G. Lorenczewski, N. Prang, C. Brandl, S. Lippold, K. Cobb, K. Brasky, E. Leo, R. Bargou, K. Murthy, and P. A. Baeuerle. 2006. T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct. Cancer Immunol. Immunother. 55:503-514.
27. Shalaby, M. R., H. M. Shepard, L. Presta, M. L. Rodrigues, P. C. Beverley, M. Feldmann, and P. Carter. 1992. Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene. J. Exp. Med. 175:217-225.
28. Staerz, U. D., O. Kanagawa, and M. J. Bevan. 1985. Hybrid antibodies can target sites for attack by T cells. Nature 314:628-631.
29. Wang, Y., Q. Liu, R. Gao, Y. Zhu, B. Hua, Y. Wang, and J. Xu. 1997. Construction of ScFv expression vector and expression of anti-HBsAg ScFv. Chin. J. Microbiol. Immunol. 17:68-71.
30. Wang, Y., Q. Liu, J. Xu, Q. Li, Y. Chen, L. Wang, and J. Li. 1998. ScFv against human RBC from phage antibody library. Chin. J. Microbiol. Immunol. 18:68-71.